Verrica Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Verrica Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $15.54. The average 1-year stock price forecast is 157.28% higher than the current stock price, while the lowest is $10 (+65.56%) and the highest is $20 (+231.13%).

Price Target: $15.54 (+157.28%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$10	$15.54	$17	$20
Change	+65.56%	+157.28%	+181.46%	+231.13%

Analyst Ratings

The average analyst rating for Verrica Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	4	4	4	4	5
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Initiates $12	Buy	Initiates	$12	+98.68%	May 26, 2026
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 13, 2026
Stacy Ku TD Cowen	TD Cowen	Buy Maintains $20	Buy	Maintains	$20	+231.13%	May 13, 2026
Kemp Dolliver Brookline Capital Markets	Brookline Capital Markets	Buy Upgrades $17	Buy	Upgrades	$17	+181.46%	Dec 18, 2025

Financial Forecast

Revenue This Year

25.53M

from 35.58M

-28.24%

from 35.58M

Revenue Next Year

46.26M

from 25.53M

81.20%

from 25.53M

EPS This Year

-1.73

from -1.24

EPS Next Year

-1.24

from -1.73

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	12.00M	9.03M	5.12M	7.57M	35.58M	25.53M
Revenue Growth	-	-24.73%	-43.27%	47.66%	370.22%	-28.24%
Gross Profit	-3.93M	-3.89M	-15.92M	-7.01M	23.28M	22.35M
Gross Margin	-32.74%	-43.08%	-310.64%	-92.70%	65.44%	87.57%
Operating Income	-30.91M	-21.30M	-63.22M	-65.84M	-11.94M	-36.46M
Net Income	-35.08M	-24.49M	-67.00M	-76.58M	-17.89M	-38.28M
EPS	-	-	-	-	-1.24	-1.73
Free Cash Flow	-18.00M	-11.08M	-17.12M	-36.41M	-15.46M	-35.75M
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	31.0M
Avg	25.5M
Low	20.2M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-12.9%
Avg	-28.2%
Low	-43.3%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-1.73
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-